TipRanks
Telix Pharmaceuticals Ltd. (AU:TLX)
ASX:TLX
Australian Market
Want to see AU:TLX full AI Analyst Report?

Telix Pharmaceuticals (TLX) Financial Statements

652 Followers

Telix Pharmaceuticals Financial Overview

Telix Pharmaceuticals's market cap is currently AU$4.59B. The company's EPS TTM is AU$0.0956; its P/E ratio is 96.73; Telix Pharmaceuticals is scheduled to report earnings on August 19, 2026, and the estimated EPS forecast is AU$0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 816.72MAU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60M
Gross Profit$ 433.78MAU$ 509.68MAU$ 314.39MAU$ 29.34MAU$ -29.77M
Operating Income$ 18.05MAU$ 82.13MAU$ 52.63MAU$ -73.18MAU$ -81.25M
EBITDA$ 40.18MAU$ 90.10MAU$ 23.15MAU$ -92.84MAU$ -70.07M
Net Income$ -7.24MAU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51M
Balance Sheet
Cash & Short-Term Investments$ 141.96MAU$ 710.35MAU$ 123.24MAU$ 116.33MAU$ 22.04M
Total Assets$ 1.18BAU$ 1.52BAU$ 406.32MAU$ 255.35MAU$ 109.81M
Total Debt$ 466.96MAU$ 581.45MAU$ 17.45MAU$ 10.45MAU$ 2.54M
Net Debt$ 325.00MAU$ -128.90MAU$ -105.79MAU$ -105.88MAU$ -19.50M
Total Liabilities$ 767.25MAU$ 948.22MAU$ 255.89MAU$ 175.35MAU$ 106.17M
Stockholders' Equity$ 415.66MAU$ 568.21MAU$ 148.91MAU$ 80.01MAU$ 2.16M
Cash Flow
Free Cash Flow$ -56.10MAU$ 9.00MAU$ 13.09MAU$ -77.83MAU$ -60.67M
Operating Cash Flow$ -17.57MAU$ 43.03MAU$ 23.88MAU$ -63.97MAU$ -59.33M
Investing Cash Flow$ -290.52MAU$ -135.17MAU$ -25.49MAU$ -17.00MAU$ -2.73M
Financing Cash Flow$ -3.78MAU$ 638.92MAU$ 10.19MAU$ 174.96MAU$ 2.85M

Telix Pharmaceuticals Earnings and Revenue History

Telix Pharmaceuticals Debt to Assets

Telix Pharmaceuticals Cash Flow

Telix Pharmaceuticals Forecast EPS vs Actual EPS